Skip to main content
MI

MH3D Inc.

The startup develops nuclear imaging technology for pre-clinical studies in small animals, utilizing high-resolution multi-isotope imaging to enhance the understanding of biological processes. This technology addresses the need for precise early detection of cancer, neurological disorders, and cardiovascular diseases, thereby improving research outcomes and accelerating drug development.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current nuclear imaging technologies for pre-clinical studies often lack the necessary resolution and sensitivity for early detection and comprehensive analysis of diseases in small animals. This limitation hinders the detailed understanding of biological processes and the development of effective treatments for cancer, neurological disorders, and cardiovascular diseases.

Solution

MH3D Inc. provides high-resolution SPECT (Single-Photon Emission Computed Tomography) scanners designed to enhance pre-clinical imaging. Their Alpha-SPECT Mini® system offers unparalleled energy resolution, enabling multi-isotope imaging for detailed analysis. The system features an ultra-wide stationary field of view, facilitating comprehensive whole-body dynamic studies in small animals. A fully stationary detector system, coupled with a dual-FOV micro-scanning aperture, optimizes imaging resolution and sensitivity across various applications, including the study of alpha-labeled radiopharmaceuticals.

Target Audience

The primary target audience includes researchers and scientists in pharmaceutical companies, universities, and research institutions conducting pre-clinical studies on small animals for cancer, neurological disorders, and cardiovascular diseases.

Features

  • Unparalleled energy resolution suitable for multi-isotope imaging
  • Ultra-wide stationary field of view for comprehensive whole-body dynamic studies
  • Fully stationary detector system coupled with a dual-FOV micro-scanning aperture
  • Optimized imaging resolution and ultrahigh sensitivity
  • Capability for studying alpha-labeled radiopharmaceuticals (alpha-RPT)
  • CZT (Cadmium Zinc Telluride) detector technology
  • OSEM (Ordered Subsets Expectation Maximization) reconstruction algorithm
This profile is AI-generated and may contain inaccuracies.